betamethasone-17,21-dipropionate has been researched along with Scalp Dermatoses in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (17.86) | 18.7374 |
| 1990's | 1 (3.57) | 18.2507 |
| 2000's | 8 (28.57) | 29.6817 |
| 2010's | 12 (42.86) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Lebwohl, M; Petersen, B | 1 |
| Cao, S; Chen, K; Chen, Y; Cheng, H; Ding, Y; Fang, H; Han, X; He, L; He, Y; Huang, J; Li, M; Li, S; Li, W; Liu, L; Lu, Q; Lu, Y; Pan, W; Wang, J; Yan, G; Zhang, C; Zhang, J; Zheng, M; Zhu, W | 1 |
| Polcz, M; Wong, D; Yeh, R | 1 |
| Calvieri, S; Camplone, G; Chimenti, S; D'Agostino, M; De Simone, C; Di Cesare, A; Filosa, G; Frascione, P; Gabellini, M; Lunghi, F; Mazzotta, A; Peris, K; Saraceno, R; Scotto Di Luzio, G; Simonacci, M | 1 |
| Debarre, JM; Gooderham, M; Goodfield, M; Keddy-Grant, J; Kurvits, M; Xu, Z | 1 |
| de Jong, EM; Donders, AR; Oostveen, AM; Seyger, MM; van de Kerkhof, PC | 1 |
| Annessi, G; Boccaletti, V; Cortelazzi, C; Di Nuzzo, S; Fabrizi, G; Fantini, C; Feliciani, C; Pagliarello, C; Zampetti, A | 1 |
| Cui, P; Facy, P; Gao, T; Ge, M; Gu, J; Hao, F; Kurvits, M; Li, R; Ma, L; Sun, Q; Wang, G; Xu, J; Xu, Z; Yang, H; Yang, Q; Zheng, M | 1 |
| Austad, J; Berne, B; Burden, AD; de Unamuno, P; Figueiredo, A; Ganslandt, C; Jemec, GB; Ortonne, JP; Poulin, Y | 1 |
| Anstey, A; Barnes, L; Bolduc, C; Hoffmann, V; Reich, K; Saari, S; Segaert, S; Vaillant, L; van de Kerkhof, PC | 1 |
| Hoffmann, V; Kragballe, K; Nordin, P; Ortonne, JP; Segaert, S; Tan, J | 1 |
| Guenther, LC | 1 |
| Augustin, M; Herberger, K; Kornek, T; Radtke, MA | 1 |
| Appell, M; Bibby, A; Foster, R; Hamilton, T; Lee, M; Mendoza, N; Tyring, S | 1 |
| Affleck, AG; Auland, M; Bottomley, JM; Jackson, P; Ryttov, J | 1 |
| Freeman, K | 1 |
| Bottomley, JM; Ryttov, J; Taylor, RS | 1 |
| Ayala, F; Cannavò, SP; Chimenti, S; De Pità, O; Girolomoni, G; Peserico, A; Vena, GA | 1 |
| Flagothier, C; Piérard, GE; Piérard-Franchimont, C; Uhoda, I | 1 |
| Downs, AM | 1 |
| Cassano, N; Vena, GA | 1 |
| Buckley, C; Cambazard, F; Hoffmann, V; Milsgaard, M; Saari, S; Shapiro, J | 1 |
| Durocher, LP; Elie, R; Kavalec, EC | 1 |
| Høvding, G | 1 |
| Hillström, L; Pettersson, L; Svensson, L | 1 |
| Bayle-Lebey, P; Bazex, J; Loche, F; Marguery, MC; Raynal, H | 1 |
| Johannesson, A; Lindelöf, B | 2 |
4 review(s) available for betamethasone-17,21-dipropionate and Scalp Dermatoses
| Article | Year |
|---|---|
Erosive pustular dermatosis of the scalp - an Australian perspective: Insights to aid clinical practice.
Topics: Algorithms; Anti-Inflammatory Agents; Australia; Betamethasone; Calcineurin Inhibitors; Curettage; Dermoscopy; Diagnosis, Differential; Glucocorticoids; Humans; Incidence; Mometasone Furoate; Recurrence; Scalp Dermatoses; Skin Diseases, Vesiculobullous; Tacrolimus | 2019 |
[Calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis. A review].
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Gels; Humans; Incidence; Psoriasis; Scalp Dermatoses; Treatment Outcome | 2010 |
Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Cost-Benefit Analysis; Drug Combinations; Gels; Humans; Models, Econometric; Psoriasis; Scalp Dermatoses; Scotland; Severity of Illness Index; Treatment Outcome | 2011 |
The effectiveness of two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of moderately severe scalp psoriasis: a systematic review of direct and indirect evidence.
Topics: Administration, Topical; Algorithms; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Drug Combinations; Evidence-Based Practice; Gels; Humans; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2011 |
16 trial(s) available for betamethasone-17,21-dipropionate and Scalp Dermatoses
| Article | Year |
|---|---|
Treating Scalp Psoriasis with Calcipotriene/Betamethasone Dipropionate Fixed-dose Combination Cutaneous Foam: Review of Phase 2 Data
Topics: Administration, Topical; Adolescent; Adult; Aerosols; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2020 |
Comparison of safety and efficacy between calcipotriol plus betamethasone dipropionate gel and calcipotriol scalp solution as long-term treatment for scalp psoriasis in Chinese patients: a national, multicentre, prospective, randomized, active-controlled
Topics: Adult; Aged; Anti-Inflammatory Agents; Asian People; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Gels; Humans; Male; Middle Aged; Prospective Studies; Psoriasis; Scalp Dermatoses; Solutions; Treatment Outcome | 2020 |
Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885 patients.
Topics: Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Male; Middle Aged; Psoriasis; Recurrence; Scalp Dermatoses; Young Adult | 2014 |
Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12-17 years of age.
Topics: Administration, Cutaneous; Adolescent; Betamethasone; Calcitriol; Child; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Female; Gels; Humans; Male; Psoriasis; Scalp Dermatoses; Treatment Outcome | 2014 |
Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population.
Topics: Administration, Topical; Adult; Asian People; Betamethasone; Calcitriol; China; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Safety; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Solutions; Treatment Outcome | 2016 |
A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Pharmaceutical Vehicles; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Skin; Treatment Outcome | 2008 |
A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Drug Administration Schedule; Drug Combinations; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Treatment Outcome; Young Adult | 2009 |
Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Young Adult | 2009 |
A calcipotriene/betamethasone dipropionate two-compound scalp formulation in the treatment of scalp psoriasis in Hispanic/Latino and Black/African American patients: results of the randomized, 8-week, double-blind phase of a clinical trial.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Black or African American; Calcitriol; Dermatologic Agents; Double-Blind Method; Drug Combinations; Hispanic or Latino; Humans; Middle Aged; Psoriasis; Scalp Dermatoses; Treatment Outcome; Young Adult | 2010 |
Dovobet ointment under occlusion overnight for troublesome scalp psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Ointments; Psoriasis; Scalp Dermatoses; Treatment Outcome | 2006 |
Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Logistic Models; Male; Maximum Tolerated Dose; Middle Aged; Patient Satisfaction; Probability; Prospective Studies; Psoriasis; Reference Values; Risk Assessment; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2008 |
Effect of salicylic acid on the activity of betamethasone-17,21-dipropionate in the treatment of erythematous squamous dermatoses.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Betamethasone; Drug Combinations; Drug Evaluation; Drug Interactions; Drug Synergism; Female; Glucocorticoids; Humans; Male; Middle Aged; Psoriasis; Salicylates; Salicylic Acid; Scalp Dermatoses | 1983 |
Treatment of psoriasis of the scalp with betamethasone 17, 21-dipropionate plus salicylic acid lotion ('Diprosalic').
Topics: Adolescent; Adult; Aged; Betamethasone; Clinical Trials as Topic; Dermatologic Agents; Drug Combinations; Female; Humans; Male; Middle Aged; Psoriasis; Salicylates; Salicylic Acid; Scalp Dermatoses; Time Factors | 1981 |
Comparison of betamethasone dipropionate lotion with salicylic acid (Diprosalic) and clobetasol propionate lotion (Dermovate) in the treatment of psoriasis of the scalp.
Topics: Anti-Inflammatory Agents; Betamethasone; Clobetasol; Drug Evaluation; Female; Humans; Hydrocortisone; Male; Psoriasis; Salicylates; Scalp Dermatoses; Suspensions | 1982 |
Psoriasis of the scalp treated with Grenz rays or topical corticosteroid combined with Grenz rays. A comparative randomized trial.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Betamethasone; Combined Modality Therapy; Glucocorticoids; Humans; Middle Aged; Psoriasis; Random Allocation; Scalp Dermatoses | 1988 |
Additional effect of grenz rays on psoriasis lesions of the scalp treated with topical corticosteroids.
Topics: Administration, Topical; Adult; Aged; Betamethasone; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Humans; Middle Aged; Psoriasis; Scalp Dermatoses | 1987 |
8 other study(ies) available for betamethasone-17,21-dipropionate and Scalp Dermatoses
| Article | Year |
|---|---|
Treatment of paediatric scalp psoriasis with calcipotriene/betamethasone dipropionate scalp formulation: effectiveness, safety and influence on children's quality of life in daily practice.
Topics: Administration, Cutaneous; Adolescent; Betamethasone; Calcitriol; Child; Child, Preschool; Drug Combinations; Female; Humans; Male; Prospective Studies; Psoriasis; Quality of Life; Scalp Dermatoses; Severity of Illness Index | 2015 |
Calcipotriol/betamethasone dipropionate ointment compared with tacrolimus ointment for the treatment of erosive pustular dermatosis of the scalp: a split-lesion comparison.
Topics: Aged, 80 and over; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Combinations; Female; Humans; Immunosuppressive Agents; Ointments; Scalp Dermatoses; Tacrolimus | 2015 |
Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Administration Schedule; Drug Combinations; Gels; Humans; Psoriasis; Scalp Dermatoses; Treatment Outcome | 2009 |
The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis - an introduction.
Topics: Administration, Topical; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Chemistry, Pharmaceutical; Drug Combinations; Humans; Psoriasis; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2011 |
Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis.
Topics: Anti-Inflammatory Agents; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Gels; Humans; Psoriasis; Quality of Life; Scalp Dermatoses; Time Factors | 2012 |
[How I treat ...scalp psoriasis].
Topics: Betamethasone; Humans; Psoriasis; Scalp Dermatoses | 2004 |
Treatment of scalp psoriasis with betamethasone dipropionate and calcipotriol two-compound product.
Topics: Adult; Aged; Betamethasone; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psoriasis; Scalp Dermatoses; Treatment Outcome | 2007 |
[A case for diagnosis: erosive pustular dermatosis of the scalp].
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents; Betamethasone; Burns; Glucocorticoids; Humans; Male; Scalp Dermatoses; Skin Diseases, Vesiculobullous | 1995 |